It is currently unknown if acute blood concentrations of GFAP are associated with post-TBI depression and/or suicidal ideation (SI) but identifying objective markers of depression and suicidality could improve clinical decision making for patients who may need long-term monitoring after TBI. The gene discussed is GFAP; the disease is major depressive disorder.